rp 73401 has been researched along with Lung Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, YR; Xia, XD; Xu, ZJ | 1 |
| Boichot, E; Corbel, M; Germain, N; Lagente, V; Lanchou, J; Martins, MA; Molet, S; R e Silva, PM | 1 |
1 review(s) available for rp 73401 and Lung Diseases
| Article | Year |
|---|---|
[Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Asthma; Benzamides; Bronchodilator Agents; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Lung Diseases; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyridines | 2004 |
1 other study(ies) available for rp 73401 and Lung Diseases
| Article | Year |
|---|---|
The selective phosphodiesterase 4 inhibitor RP 73-401 reduced matrix metalloproteinase 9 activity and transforming growth factor-beta release during acute lung injury in mice: the role of the balance between Tumor necrosis factor-alpha and interleukin-10.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Benzamides; Blotting, Western; Bronchoalveolar Lavage Fluid; Cyclic Nucleotide Phosphodiesterases, Type 4; Endotoxins; Interleukin-10; Lipopolysaccharides; Lung Diseases; Male; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Phosphodiesterase Inhibitors; Protease Inhibitors; Pyridines; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2002 |